Manufacturer of Blu Vapes, Tianchang Group, Sees Decline in E-Cigarette Sales

Business by Alice Wang
Jun.15.2023
Manufacturer of Blu Vapes, Tianchang Group, Sees Decline in E-Cigarette Sales
Tianchang Group's e-cigarette sales decreased by 68% due to the loss of a major client, Blu.

On June 14th, the Hong Kong Stock Exchange-listed company, Tianchang Group, announced that compared to the same period last year, the group has recorded a decrease of approximately 68% in sales revenue for e-cigarette products.

 

Tianchang Group attributes their decline in sales to "the customer hiring other manufacturers to produce e-cigarette products, which resulted in a corresponding decrease in sales orders from the customer."

 

The company stated that it will continue to monitor the effects of the removal of exclusive rights clauses and the manufacturing and sales of its different products. It also aims to broaden its customer base by seeking new clients to purchase high-quality e-cigarette products, as the group is no longer bound by exclusive rights clauses to manufacture and sell e-cigarette products for a specific customer.

 

blu代工厂天长集团:电子烟销售额下滑68%  客户转向其他制造商
Public Announcement | Tianchang Group

 

According to reports, Tianchang Group is an integrated injection molding solution provider, focused on mold design and manufacturing services, as well as injection component design and manufacturing services. In recent years, the company has expanded its business to manufacture e-cigarette products through OEM. Tianchang Group has previously acted as an original equipment manufacturer (OEM) for the e-cigarette brand "Blu," owned by Imperial Tobacco.

 

blu代工厂天长集团:电子烟销售额下滑68%  客户转向其他制造商
Blu Product Catalogue | Tianchang Group Official Website

 

Reference:

 

The official announcement of Tianchang Group.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Company | PMI Survey: 60% of U.S. Voters Support a “New Path” for Tobacco Control, Backing Policies that Encourage Switching to Lower-Risk Alternatives
Company | PMI Survey: 60% of U.S. Voters Support a “New Path” for Tobacco Control, Backing Policies that Encourage Switching to Lower-Risk Alternatives
An article on Philip Morris International’s (PMI) website indicates that U.S. likely voters generally hold reserved or negative views of the FDA’s performance on public health and tobacco regulation, with only about 36% expressing approval. Two nationwide polls show that more than six in ten respondents support reducing smoking rates through new approaches rather than relying solely on higher taxes and restrictions; over half support policies that encourage adult smokers to switch to non-combust
Sep.03 by 2FIRSTS.ai
BAT Partners with Accenture in Global Strategic Collaboration to Advance Supply Chain and AI Transformation
BAT Partners with Accenture in Global Strategic Collaboration to Advance Supply Chain and AI Transformation
BAT has formed a global strategic partnership with Accenture to enhance operational efficiency and supply chain transformation through technology and innovation. The collaboration aims to upskill employees, boost agility, and support sustainable growth.
Aug.01 by 2FIRSTS.ai
Caixin Reports: Yiling’s Atomizer Sparks Public Concern as Experts Call for Stronger Oversight
Caixin Reports: Yiling’s Atomizer Sparks Public Concern as Experts Call for Stronger Oversight
Caixin reports that a Yiling Pharmaceutical subsidiary’s atomizer, resembling an e-cigarette, has sparked public concern. Experts classify herbal atomizers as e-cigarettes and call for stricter oversight. China’s tobacco regulator has confirmed such products fall under e-cigarette rules and pledged to maintain strict enforcement.
Jul.31
Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time
Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time
Singapore’s Ministry of Health plans to classify nitazenes, a sedative found in one-third of tested e-cigarettes, as a Class C controlled substance under the Misuse of Drugs Act. The move follows reports of related fatalities. Once enforced, offenders could face mandatory rehabilitation and imprisonment, similar to penalties for hard drugs.
Jul.21 by 2FIRSTS.ai
Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
Philip Morris International: When High Valuation Meets Flawed Performance — A 2Firsts Reader Submission
After PMI released its Q2 2025 earnings, a 2Firsts reader submitted an in-depth analysis unpacking key concerns behind the headline numbers. While earnings beat expectations, slowing organic revenue growth, challenges in combustibles and ZYN, and a low margin for error under high valuation have triggered market unease. The next few quarters may prove pivotal for PMI’s growth narrative.
Jul.24
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
2Firsts Interview | Malawi’s Economic Engine: TAMA Farmers Trust CEO Reflects on the Current Marketing Season and Malawi’s Heavy Tobacco Dependence
Malawi relies heavily on tobacco, which generates over 50% of foreign exchange and 12% of GDP. In 2025, output is expected to reach 175 million kg, but lower prices and rising costs hurt profits. TAMA CEO Nixon Lita discusses climate effects, market pressures, diversification, and challenges from next-generation nicotine products.
Jul.30